Biotech firms, Hub hospitals strengthen ties

Two Boston teaching hospitals are stepping up research into cardiovascular disease in separate programs that illustrate the deepening collaboration between academic medical centers and the biopharmaceutical industry.

Brigham and Women’s Hospital, meanwhile, will open the Center for Interdisciplinary Cardiovascular Sciences in a partnership with Japanese drug maker Kowa Company Ltd. to conduct basic research into the genesis of diseases such as atherosclerosis and diabetes. The Kowa-funded center, which will be the largest of the Boston hospital’s global pharmaceutical collaborations, will employ about 12 researchers in the Longwood Medical Area.

Read more here (Boston Globe)